Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Morgan Stanley raises dividend 15% and approves $20B buyback program
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal